Microvesicles, with the exception of endothelial derived microvesicles, were unaffected.
In Paper III, seventeen healthy volunteers inhaled e-cigarette vapor with and without nicotine.
So far, there is limited data available on the potential negative health effects of e-cigarette smoking.
The overall aim of this thesis was to investigate vascular health effects caused by acute cigarette and e-cigarette inhalation as well as chronic snus usage.
In this double-blinded, randomized, cross-over study arterial stiffness was analyzed at baseline and at predetermined intervals for 4 hours following exposure.
E-cigarette vapor inhalation containing nicotine caused a transient acute increase in heart rate and arterial stiffness.Biomarkers were analyzed in the same approach as in Paper I.E-cigarette inhalation caused an acute increase in endothelial progenitor cells.This elucidates that nicotine alone may alter endothelial function, both upon acute and chronic exposure.Snus users also display an attenuated effect of glyceryl tri-nitrate which further strengthens the findings that snus use is associated with increased mortality following myocardial infarction.Your access to the NCBI website at gov has been temporarily blocked due to a possible misuse/abuse situation involving your site.This is not an indication of a security issue such as a virus or attack.However, with the public’s increasing awareness of the harm and diseases related directly to cigarette smoke, alternative combustion-free nicotine delivery products have gained in popularity.Two of the products which have seen substantial market growths during the last few years are Swedish snus and electronic cigarettes.The effects of smoking on levels of endothelial progenitor cells and microparticles in the blood of healthy volunteers. Antoniewicz L, Bosson JA, Kuhl J, Abdel-Halim S, Kiessling A, Mobarrez F, Lundbäck M.Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers. 2016;29-85 Fulltext (DOI) Pubmed View record in Web of Science® III.